SCOTUS rules Indiana farmer is 'seed thief,' upholds Monsanto's seed patents

Seeds by Shutterstock.com

Article Highlights

  • Bowman v. Monsanto affirmed that growing a crop of seeds is “making” those seeds, and is covered under patent law.

    Tweet This

  • Bowman v. Monsanto could have long-term implications for other self-replicating innovative technologies.

    Tweet This

As expected, the Supreme Court ruled that a farmer cannot reproduce patented seeds through planting and harvesting without permission of the patent holder—in this case, Monsanto. The justices, all but stating that Vernon Bowman attempted to steal Monsanto’s seeds, unanimously rejected the Indiana soybean farmer’s argument that Monsanto’s patent “exhausted” when he purchased seeds from a grain elevator to plant on his farm. The ruling affirmed that the act of growing a crop of seeds is “making” those seeds, and is covered under patent law.

It was a narrow ruling that applied only to seed patents and the particulars of this case, but it could have long-term implications for other self-replicating innovative technologies.

The unanimous ruling written by Justice Elena Kagan hinted at the deception at the center of Bowman’s actions and argument:

The exhaustion doctrine does not enable Bowman to make additional patented soybeans without Monsanto’s permission (either express or implied). And that is precisely what Bowman did. He took the soybeans he purchased home; planted them in his fields at the time he thought best; applied glyphosate to kill weeds (as well as any soy plants lacking the Roundup Ready trait); and finally harvested more (many more) beans than he started with. That is how “to ‘make’ a new product,” to use Bowman’s words, when the original product is a seed.

Based on the grilling the justices gave Bowman’s lawyers in February, the ruling was anticipated. Monsanto has invested hundreds of millions of dollars developing the world’s top selling genetically modified seed and was granted patent protection for its investment.

“Why in the world would anybody spend any money to try to improve the seed if as soon as they sold the first one anybody could grow more and have as many of those seeds as they want?” Chief Justice John Roberts had mused during oral arguments.

The seeds are engineered to require the use of less weed killers than used by conventional farmers, who use chemical sprays that can damage crops and reduce yields. It is specifically modified to be used with glyphosate, marketed by Monsanto as Roundup, an herbicide considered less harmful to crops, less environmentally harmful than the range of pesticides used in conventional farming and toxicologically benign.

Bowman v Monsanto revolved around what Bowman contended was a legal loophole in his license agreement with Monsanto: farmers are allowed to sell the second-generation seeds to grain elevators, which, in turn, are permitted to sell a mixture of undifferentiated seeds as “commodity grain.” In other words, he maintained he was legally allowed to buy Monsanto’s seeds cheaper from a grain elevator rather than directly from the company. Monsanto contended that commodity grain is restricted for use as feed, not cultivation, and its use, even as a second year commodity purchase violates the one-time use license agreement.

Bowman’s case fell apart because of a deception at the heart of his argument. Bowman purchased Roundup Ready seeds for one year. The next season, Bowman cleverly (as anti-Monsanto and anti-GMO activists would have it) or deviously (as Monsanto, the biotechnology industry, the US government, many universities, most patent experts and apparently SCOTUS believe) recognized that the commodity soy bean seeds sold by local grain elevators probably contained mostly Roundup Ready seeds. He guessed he could save a bundle at Monsanto’s expense by discontinuing buying the Monsanto version and instead purchasing far less expensive local commodity seeds.

When Bowman treated his second crop with herbicide, he was proved right—most of the plants were resistant. He had effectively circumvented the license restrictions. Monsanto sued him for infringing its Roundup Ready patents by using, without authorization, second-generation seeds embedded with its technology. The company contended and SCOTUS agreed that if Bowman prevailed in this case, farmers could save seeds from one year’s crop to plant the following year, decimating its hard-earned patent rights.

What are the implications of the decision? As Karl Haro von Mogel writes on Biofortified, although the justices stressed this was a narrow decision riding on the specifics of this case, it has broader implications. “Farmers actively create or make seeds when they grow crops,” he notes. “The very readable ruling spent considerable effort to outline the reasons why exhausting a patent after only one generation of growing a crop from genetically engineered seeds would effectively undermine the entire patent concept, and reduce the patent monopoly from twenty years to less than one. Their reasoning was motivated by the directives of Congress on maintaining reliable incentives for the invention of new and useful technologies.”

The Court also rejected an argument advanced by the Center for Food Safety that planting is the natural consequence of seeds, even they are sold by a grain elevator with the intention of being processed into food or other products. CFS had argued in a silly commentary in the Los Angeles Times that a genetically engineered seed developed at an investment of millions of dollars and requiring years of evaluation and testing should be treated as a commodity because they are “natural”—which is a direct contradiction of the propaganda on its website.

As von Mogel notes, “The Center for Food Safety, which filed a brief in support of Bowman, has long argued that genetically engineered crops are not natural, so this apparent change in position brought about by this argument was significant. If the seeds are not natural, then there is no precedent set that the ‘natural and foreseeable use’ of them is for replanting. Therefore, contrary to previous statements, they needed to argue in favor of the naturalness of growing second-generation genetically engineered seeds. The term ‘natural’ was used widely in the brief filed by CFS. SCOUTS soundly rejected Bowman’s position as advanced by CFS.

Bowman himself stands in a peculiarly poor position to assert such a claim. As noted earlier, the commodity soybeans he purchased were intended not for planting, but for consumption. Indeed, Bowman conceded in deposition testimony that he knew of no other farmer who employed beans bought from a grain elevator to grow a new crop. So a non-replicating use of the commodity beans at issue here was not just available, but standard fare.

Of course, the ruling brought immediate howls from anti-biotechnology crusaders and fringe activist groups. Truth Out put America on notice that “According to the US Supreme Court, Monsanto as the right to control our food supply.” The Center for Food Safety, at least so far, has had no response to the ruling.

Jon Entine, executive director of the Genetic Literacy Project, is a senior fellow at the Center for Health & Risk Communication and STATS (Statistical Assessment Service) at George Mason University.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Jon
Entine
  • Jon Entine, a former Emmy-winning producer for NBC News and ABC News, researches and writes about corporate responsibility and science and society. His books include No Crime But Prejudice: Fischer Homes, the Immigration Fiasco, and Extra-Judicial Prosecution (TFG Books, May 2009), about prosecutorial excesses; Abraham's Children: Race, Identity, and the DNA of the Chosen People (Grand Central Publishing, 2007), which focuses on the genetics of race; Let Them Eat Precaution: How Politics Is Undermining the Genetic Revolution in Agriculture (AEI Press, 2006), about the genetic modification of food and farming; Pension Fund Politics: The Dangers of Socially Responsible Investing (AEI Press, 2005), which reveals the effects of social investing on pension funds; and the best-selling Taboo: Why Black Athletes Dominate Sports and Why We're Afraid to Talk about It (Public Affairs, 2000), based on an award-winning NBC News documentary. Currently, Mr. Entine is an adviser to Global Governance Watch (GGW), a project that examines transparency and accountability issues at the United Nations (UN), in nongovernmental organizations (NGOs), and in related international organizations. GGW also analyzes the impact of UN agencies and NGOs on government and corporations. He is also working on a book exploring the revolutionary impact of genomic research on medical treatments and traditional perceptions of human limits and capabilities.


    Follow Jon Entine on Twitter.
  • Phone: 513-319-8388
    Email: jentine@aei.org

What's new on AEI

image The Census Bureau and Obamacare: Dumb decision? Yes. Conspiracy? No.
image A 'three-state solution' for Middle East peace
image Give the CBO long-range tools
image The coming collapse of India's communists
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.